TSE News

TOKYO AIM Accepts Listing of Mebiopharm

Update : Jun. 24, 2011

print

[Tokyo Stock Exchange, Inc.]

TOKYO AIM Inc., (“TOKYO AIM”) today announced that it has accepted the initial listing of Mebiopharm Co., Ltd. (“Mebiopharm”), a Japanese biotechnology firm, specializing in new drug development for cancer treatment. The expected listing date is July 15, 2011.

Further details on TOKYO AIM can be found at:

Contact

Tokyo Stock Exchange Group, Inc.
Corporate Strategy
Tel: +81-3-3666-1361

Top of Page